ALIM Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally...

Stats
Dagens volum	143 580
Gjennomsnittsvolum	71 388.00
Markedsverdi	191.17M
EPS	$0 ( 2024-03-07 )
Neste inntjeningsdato	( $-0.0400 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.35
ATR14	$0.0200 (0.54%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-26	Ashman Philip	Sell	12 103	Common Stock
2024-03-11	Werner Jason M.	Buy	1 800	Restricted Stock Units
2024-03-11	Wood Todd Michael	Buy	125 000	Performance-Based Restricted Stock Units
2024-03-11	Wood Todd Michael	Buy	125 000	Restricted Stock Units
2024-03-11	Eiswirth Richard S Jr	Buy	14 700	Restricted Stock Units

INSIDER POWER
27.03
Last 77 transactions
Buy: 33 555 909 \| Sell: 20 075 544

Volum Korrelasjon

Lang: 0.06 (neutral)

Kort: -0.25 (neutral)

Signal:(41.28) Neutral

Alimera Sciences Inc Korrelasjon

10 Mest positive korrelasjoner
ADV	0.943
RCMT	0.942
BTWN	0.941
AMZN	0.933
USLM	0.933
KE	0.93
RXST	0.929
HUSN	0.928
MRAM	0.928
ALTO	0.928

10 Mest negative korrelasjoner
AKU	-0.948
IMBI	-0.942
AMRB	-0.936
RMBS	-0.93
STRM	-0.928
AGRI	-0.927
ENNV	-0.924
LOPE	-0.923
EYEN	-0.921
PTMN	-0.919

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Alimera Sciences Inc Korrelasjon - Valuta/Råvare

-0.85
( strong negative )

-0.87
( strong negative )

0.00
( neutral )

-0.84
( strong negative )

0.13
( neutral )

0.78
( moderate )

Alimera Sciences Inc Økonomi

Annual	2023
Omsetning:	$80.75M
Bruttogevinst:	$61.17M (75.75 %)
EPS:	$-0.790

FY	2023
Omsetning:	$80.75M
Bruttogevinst:	$61.17M (75.75 %)
EPS:	$-0.790

FY	2022
Omsetning:	$54.13M
Bruttogevinst:	$46.15M (85.26 %)
EPS:	$-2.59

FY	2021
Omsetning:	$59.03M
Bruttogevinst:	$52.00M (88.09 %)
EPS:	$-0.854

Financial Reports:

No articles found.

Alimera Sciences Inc

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.